Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
Translational results from the Swedish randomised phase III, TEX trial show that breast cancer relapse characteristics display aggressive features, with an over-representation of ER-negative, HER2-positive and highly proliferative tumours.
The molecular subtype of breast cancer metastases significantly influences post-relapse survival, according to the study findings presented by Dr Nicholas Tobin of the Karolinska Institute, Stockholm, Sweden.
Click here to read the article in full.
Source: ESMO
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.